<em>Association For Molecular Pathology v. U.S. Patent and Trademark Office</em> is a victory for companies with DNA patents, but the case could return to the Supreme Court
October 30, 2012 at 12:00 AM
1 minute read
The original version of this story was published on Law.com
The Federal Circuit’s decision was a tremendous victory for the biotech industry. Or so it seemed.
The court on Aug. 16 held that human DNA can be patented. The 2-1 ruling in Association For Molecular Pathology v. U.S. Patent and Trademark Office reaffirmed the panel’s prior decision in the case and rejected again the contention that human DNA is an unpatentable product of nature.
Presented by BigVoodoo
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
Philadelphia Plaintiff litigation firm seeks an associate attorney with at least 2 years' experience to join our team handling personal inju...
Position OverviewThe United States Judicial Panel on Multidistrict Litigation is accepting applications for the full-time, permanent positio...
A prominent AV-rated Education Law firm seeks an associate with 5+ years experience. The role will primarily involve advice and counsel in ...
